InvestorsHub Logo
Followers 12
Posts 909
Boards Moderated 0
Alias Born 12/30/2004

Re: None

Wednesday, 05/04/2016 10:49:00 AM

Wednesday, May 04, 2016 10:49:00 AM

Post# of 113894
For anyone rolling the dice on specialty pharma, AMAG ($20.85) looks interesting. Down 19% in 2 days after they missed Q1 estimates but re-iterated full-year guidance. Trading @ 4x 2016 estimates and under book value. USA-based, unlike HZNP, ENDP, VRX.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.